Condition: Oropharynx Cancer · Larynx Cancer · Hypopharynx Cancer · Sponsor: Centre Leon Berard
The aim of this study is to investigate the effect of ATRA (Vesanoid) and the effect of tailored radiotherapy in patients with squamous cell carcinoma of the oropharynx, larynx or hypopharynx.
This description comes directly from the study's public registry record.
Vincent Grégoire, PhD · 4 69 85 62 53 · vincent.gregoire@lyon.unicancer.fr
Always discuss trial participation with your own doctor first.
| Centre Léon Bérard | Lyon, France, France | Recruiting |
| Institut de Cancérologie de Lorraine | Vandœuvre-lès-Nancy, France, France | Recruiting |
| Institut Gustave Roussy | Villejuif, France, France | Recruiting |
| Institut de Cancérologie de l'Ouest - Paul Papin | Angers, France | Recruiting |
| Centre Oscar Lambret | Lille, France | Recruiting |
| Centre Antoine Lacassagne | Nice, France | Recruiting |
| AP-HP - Hôpital Tenon | Paris, France | Recruiting |
| Institut Godinot | Reims, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06706401